News & Analysis as of

U.S. Department of Agriculture Prescription Drugs

Wiley Rein LLP

[Podcast] Food for Thought and Thoughts on Food: What to Expect in 2023

Wiley Rein LLP on

On this episode, Amaru Sánchez and Bob Hibbert discuss trends you can expect to see in the food and drug space in the coming year. Beginning with the emerging market of cultivated protein, Amaru and Bob cover what is next for...more

BakerHostetler

FDA and Pharmacy Weekly Digest - January 2020 #2

BakerHostetler on

Food/Dietary Supplements - Court Enters Consent Decree Against Food Facility – A Michigan-based food manufacturer will “discontinue selling food products until the company complies with federal regulations and other...more

Wilson Sonsini Goodrich & Rosati

Sitting Here on Capitol Hill: Congressional Developments on Life Science and Consumer Product Issues

Letters and Statements - Gene Therapy: Democratic Senators Urge the FDA to Hold Company Accountable for Falsifying Data - On August 9, 2019, a group of Democratic senators, including two presidential candidates, sent...more

BakerHostetler

FDA and Pharmacy Weekly Digest - March 2019 #2

BakerHostetler on

FDA Commissioner Announces Resignation – Food and Drug Administration Commissioner Scott Gottlieb announced his resignation, citing personal reasons. ...more

BakerHostetler

BakerHostetler FDA and Pharmacy Weekly Digest - November 2018 #4

BakerHostetler on

Food/Dietary Supplements - Romaine Lettuce Investigation – The Food and Drug Administration (FDA) is investigating a multistate outbreak of E. coli likely linked to romaine lettuce....more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

To no one’s surprise, the Fed followed through with its months of promises and raised its benchmark interest rate by 25 basis points yesterday. The FOMC also indicated that it’s planning to raise rates again in December....more

BakerHostetler

First Amendment Right to Off-Label Promotion – Has Pandora’s Box Been Opened for FDA?

BakerHostetler on

A handful of recent court decisions, including one issued just last month, seems to have potentially cracked open the door for pharmaceutical manufacturers to have more leeway to promote off-label uses of their products....more

Mintz - Health Care Viewpoints

Health Care Reform Update -- July 1, 2013

In This Issue: Leading the News; Implementation of the Affordable Care Act; Other HHS and Federal Regulatory Initiatives; Other Congressional and State Initiatives; Other Health Care News; and Hearings and Mark-Ups...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide